Laban, Natasha Makabilo
Goodier, Martin Rhys
Chilengi, Roma
Ng’ombe, Harriet
Chauwa, Adriace
Bosomprah, Samuel
Funding for this research was provided by:
Wellcome Trust (211356/Z/18/Z)
European and Developing Countries Clinical Trials Partnership (TMA2016SF-1511-ROVAS-2)
Article History
Received: 28 June 2024
Accepted: 14 October 2025
First Online: 18 November 2025
Declarations
:
: This study was approved by the National Health Research Authority of Zambia who waived the need for consent to participate based on the existing ethical approval for the parent rotavirus vaccine trial obtained by the University of Zambia Biomedical Research Ethics (Reference number: 003-02-18). Informed consent was obtained from all participants enrolled under the rotavirus vaccine trial.
: Not applicable.
: The authors declare no competing interests.